 | Mirum Pharmaceuticals, Inc. | |||
| NGM : MIRM || Location: United States | ||||
$24.5+0.48 (+2.02%) |
0.42 M | 23.14 - 24.62 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 8.575 M |
| March 28, 2024 | 8.161 M |
| March 15, 2024 | 8.138 M |
| Feb. 29, 2024 | 7.662 M |
| Feb. 15, 2024 | 7.778 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.25 | -0.66 | -166.24% |
| 09/30/2023 | -0.64 | -0.57 | 11.08% |
| 06/30/2023 | -0.81 | -1.94 | -139.12% |
| 03/31/2023 | -0.96 | -0.80 | 16.41% |
| 12/31/2022 | -1.04 | -0.99 | 4.80% |
MIRM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 47.118M | Shares Float | 35.192M |
| Short Float | 8.575M | Market Cap | 1129.01M |
| Institution ownership | 0.00% | Insider ownership | 2.249% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -4.00 | Forward EPS | 0.51 |